Dr. Thorvardur R Halfdanarson M.D.
Oncologist | Medical Oncology
200 Hawkins Dr Iowa City IA, 52242About
Dr. Thorvardur Halfdanarson is an oncologist practicing in Iowa City, IA. Dr. Halfdanarson specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Halfdanarson manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
University Of Iceland, Faculty Of Medicine MD
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Extra-hepatic hepatocellular carcinoma presenting as obstructive jaundice.
- Copper deficiency in celiac disease.
- Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.
- Chocolate as a cough suppressant: rationale and justification for an upcoming clinical trial.
- Severe autoimmune neutropenia associated with acute autoimmune hepatitis.
- Oral cancer chemotherapy: the critical interplay between patient education and patient safety.
- Obesity adversely affects survival in pancreatic cancer patients.
- Incidence and management of gastrointestinal perforation from bevacizumab in advanced cancers.
- Current status and perspectives of targeted therapy in well-differentiated neuroendocrine tumors.
- Establishing a standard of care for small bowel adenocarcinomas: challenges and lessons learned.
- Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the Cancer Care Outcomes Research and Surveillance Consortium.
- Extravasation of oxaliplatin into the mediastinum: a case report and review of the literature.
- Molecular markers for novel therapeutic strategies in pancreatic endocrine tumors.
- Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial.
- Incretins and risk of neoplasia.
Clinical Trials
Dr. Thorvardur R Halfdanarson M.D.'s Practice location
Dr. Thorvardur R Halfdanarson M.D.'s reviews
Write ReviewPatient Experience with Dr. Halfdanarson
Recommended Articles
- Everything You Need To Know About Chemotherapy
What is Chemotherapy?Chemotherapy is a type of treatment used in treating cancer. It is used to destroy cancer cells. In other cases, chemotherapy drugs suppress cancer cells, destroy them or reduce their rate of spreading. These drugs are well known as anticancer drugs. What Does a Chemotherapy...
- New Clinical Trial: Genetically Enhanced Immune Cells for Lymphoma Treatment
B-cell cancers, or cancers that target B-lymphocytes, have been particularly hard to treat in recent years. Recent breakthroughs have led to the conclusion that B-cell cancer can be effectively combated with the use of programmed immune cells.How it WorksThe immune system creates cells that are able...
- Is it Possible to Recover from Stage IV Breast Cancer?
Whether you have just recently been diagnosed with stage IV breast cancer, or you are just now recovering from the shock, you are certainly filled with bewilderment and confusion with all of the information that has been thrown at you in such a short period of time. The moment you first heard those...
- Researches Discover Clues as to Why Exactly BRCA Mutations Can Cause Cancer
When the BRCA1 gene mutation was found by scientists supported by the National Cancer Institute to be hereditary predisposition to breast cancer, it was a major breakthrough; however, for many years, researchers have found themselves puzzled by the BRCA1 gene. Its ability to cause breast and ovarian...
- Comparative Value of PARP Inhibitors is Lacking, According to ICER Report
The Institute for Clinical and Economic Review, also known as ICER, is a non-profit organization that analyzes the value of new medical tests, treatments, and drugs approved by the U.S. Food and Drug Administration (FDA). The goal of ICER is to use the value of these innovations and develop reports...
- What are the Signs and Symptoms of Lung Cancer?
Lung cancer is one of the most common cancers in the world. It is a leading cause of cancer death in men and women worldwide. Lung cancer defies classification as a single disease affecting just one organ. The warning signs and painful symptoms represent major systemic disorders in different parts...
Nearby Providers
- Dr. Matthew Obinna Nwaneri M.D.200 HAWKINS DR IOWA CITY IA 52242
- Dr. Michael H Tomasson MD200 HAWKINS DR IOWA CITY IA 52242
- Dr. Evelena Ontiveros MD PHD200 Hawkins Dr Iowa City IA 52242
- Dr. Gerald H Clamon MD200 Hawkins Dr Iowa City IA 52242
- Dr. Mark W Karwal MD200 Hawkins Dr Iowa City IA 52242
- Dr. Roger D Gingrich MD200 Hawkins Dr Iowa City IA 52242